Jazz Pharmaceuticals plc (JAZZ) Announces Participation in Upcoming Investor Events
5/14/2013 6:58:39 AM
More...
|
Jazz Pharmaceuticals plc (JAZZ) Announces First Quarter 2013 Financial Results
5/8/2013 6:45:05 AM
More...
|
Jazz Pharmaceuticals plc (JAZZ) to Report First Quarter 2013 Financial Results on May 7, 2013
4/24/2013 6:25:53 AM
More...
|
Jazz Pharmaceuticals plc (JAZZ) Announces Pricing of Public Offering of Ordinary Shares by Selling Shareholders
3/5/2013 10:48:00 AM
More...
|
Jazz Pharmaceuticals plc (JAZZ) Announces Public Offering of Ordinary Shares By Selling Shareholders
3/5/2013 9:35:26 AM
More...
|
Concert Pharmaceuticals, Inc., Jazz Pharmaceuticals plc (JAZZ) Strike $120 Million Deal for Narcolepsy
2/27/2013 7:31:38 AM
More...
|
Jazz Pharmaceuticals plc (JAZZ) Announces Participation at Two Investor Conferences in March
2/27/2013 7:28:27 AM
More...
|
Jazz Pharmaceuticals plc (JAZZ) Reports Full Year and Fourth Quarter 2012 Financial Results
2/27/2013 6:59:23 AM
More...
|
Jazz Pharmaceuticals plc (JAZZ) to Report 2012 Fourth Quarter and Full Year Financial Results on February 26, 2013
2/12/2013 6:23:54 AM
More...
|
Jazz Pharmaceuticals plc (JAZZ) Announces Issuance of Additional Xyrem® Patent
12/5/2012 8:59:01 AM
More...
|
|